Resultats globals: 3 registres trobats en 0.03 segons.
Articles, 3 registres trobats
Articles 3 registres trobats  
1.
15 p, 1.7 MB Evolution of Pharmacological Treatments and Associated Costs for Multiple Myeloma in the Public Healthcare System of Catalonia : A Retrospective Observational Study / Garrido-Alejos, Gemma (Universitat Autònoma de Barcelona. Departament de Farmacologia, de Terapèutica i de Toxicologia) ; Saborit-Canals, Guillem (Servei Català de la Salut) ; Guarga, Laura (Servei Català de la Salut) ; de Pando, Thais (Institut d'Investigació Biomèdica de Bellvitge) ; Umbria, Miriam (Servei Català de la Salut) ; Oriol, Albert (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Feliu, Anna (Institut d'Investigació Biomèdica Sant Pau) ; Pontes García, Caridad (Institut d'Investigació Biomèdica de Bellvitge) ; Vallano, Antonio (Universitat Autònoma de Barcelona. Departament de Farmacologia, de Terapèutica i de Toxicologia)
In this study, we examined the prescription patterns and pharmaceutical costs for treatments of multiple myeloma (MM) in Catalonia's public healthcare system over the past decade. MM is a complex and costly disease for which substantial pharmacological innovation has recently been introduced, and we aimed to understand how treatment choices and expenses have evolved. [...]
2023 - 10.3390/cancers15225338
Cancers, Vol. 15 (november 2023)  
2.
12 p, 1019.0 KB Incidence and time trends of childhood hematological neoplasms : a 36-year population-based study in the southern European context, 1983-2018 / Trallero, Jan (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Sanvisens, Arantza (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Almela Vich, Fernando (Valencian Community Department of Universal Health and Public Health) ; Jeghalef El Karoni, Noura (Valencian Community Department of Universal Health and Public Health) ; Saez Lloret, Isabel (Valencian Community Department of Universal Health and Public Health) ; Díaz-del-Campo, Cristina (Health and Social Welfare Authority, Ciudad Real) ; Marcos-Navarro, Ana Isabel (Health and Social Welfare Authority, Cuenca) ; Aizpurua Atxega, Amaia (Basque Country Cancer Registry, Basque Government, Vitoria-Gasteiz) ; Sancho Uriarte, Patricia (Basque Country Cancer Registry, Basque Government, Vitoria-Gasteiz) ; De-la-Cruz Ortega, Marta (Basque Country Cancer Registry, Basque Government, Vitoria-Gasteiz) ; Sánchez, María José (University of Granada) ; Perucha, Josefina (Epidemiology and Health Prevention Service, Logroño) ; Franch, Paula (Institut d’Investigació Sanitària Illes Balears) ; Chirlaque, María Dolores (Instituto Murciano de Investigación Biosanitaria) ; Guevara, Marcela (Instituto de Salud Pública de Navarra) ; Ameijide, Alberto (Institut d'Investigació Sanitària Pere Virgili) ; Galceran, Jaume (Institut d'Investigació Sanitària Pere Virgili) ; Ramírez, Cristina (Health and Social Welfare Authority, Albacete) ; Rodríguez Camblor, Marta (Asturias Cancer Registry, Public Health Directorate) ; Alemán, Maria Araceli (Public Health Directorate, Tenerife) ; Gutiérrez, Pilar (Public Health Directorate, Valladolid) ; Marcos-Gragera, Rafael (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras)
Background: Hematological neoplasms (HNs) are the first and most common childhood cancers globally. Currently, there is a lack of updated population-based data on the incidence of these cancers in the Spanish pediatric population. [...]
2023 - 10.3389/fonc.2023.1197850
Frontiers in Oncology, Vol. 13 (july 2023)  
3.
11 p, 1.8 MB Aneuploidy in Cancer : Lessons from Acute Lymphoblastic Leukemia / Molina, Oscar (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Abad, Maria Alba (Wellcome Center for Cell Biology. University of Edinburgh) ; Sole, F (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Menéndez Bujan, Pablo (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Universitat Autònoma de Barcelona
Aneuploidy, the gain or loss of chromosomes in a cell, is a hallmark of cancer. Although our understanding of the contribution of aneuploidy to cancer initiation and progression is incomplete, significant progress has been made in uncovering the cellular consequences of aneuploidy and how aneuploid cancer cells self-adapt to promote tumorigenesis. [...]
2021 - 10.1016/j.trecan.2020.08.008
Trends in Cancer, Vol. 7 Núm. 1 (january 2021) , p. 37-47  

Us interessa rebre alertes sobre nous resultats d'aquesta cerca?
Definiu una alerta personal via correu electrònic o subscribiu-vos al canal RSS.